BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17598016)

  • 1. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
    Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
    Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
    Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.
    Johnson JL; George SJ; Newby AC; Jackson CL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15575-80. PubMed ID: 16221765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
    J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.
    Johnson JL; Baker AH; Oka K; Chan L; Newby AC; Jackson CL; George SJ
    Circulation; 2006 May; 113(20):2435-44. PubMed ID: 16702468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice.
    de Nooijer R; von der Thüsen JH; Verkleij CJ; Kuiper J; Jukema JW; van der Wall EE; van Berkel JC; Biessen EA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2313-9. PubMed ID: 15472128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
    Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
    Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.
    Martin-McNulty B; Zhang L; da Cunha V; Vincelette J; Rutledge JC; Vergona R; Sullivan ME; Wang YX
    Transl Res; 2007 Feb; 149(2):70-5. PubMed ID: 17240317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.
    Fukumoto Y; Deguchi JO; Libby P; Rabkin-Aikawa E; Sakata Y; Chin MT; Hill CC; Lawler PR; Varo N; Schoen FJ; Krane SM; Aikawa M
    Circulation; 2004 Oct; 110(14):1953-9. PubMed ID: 15451791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice.
    Bentzon JF; Sondergaard CS; Kassem M; Falk E
    Circulation; 2007 Oct; 116(18):2053-61. PubMed ID: 17938286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement.
    Tang YL; Yang YZ; Wang S; Huang T; Tang CK; Xu ZX; Sun YH
    Chin Med J (Engl); 2009 Feb; 122(3):319-25. PubMed ID: 19236812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity.
    Lessner SM; Martinson DE; Galis ZS
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2123-9. PubMed ID: 15308548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method of plaque rupture induction in apolipoprotein E-deficient mice.
    Sasaki T; Kuzuya M; Nakamura K; Cheng XW; Shibata T; Sato K; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1304-9. PubMed ID: 16574894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there life after plaque rupture?
    Jackson CL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):887-9. PubMed ID: 17956238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.